Bio-Techne (TECH) Misses Q3 EPS by 8c

Bio-Techne (NASDAQ: TECH) reported Q3 EPS of $0.81, $0.08 worse than the analyst estimate of $0.89. Revenue for the quarter came in at $131 million versus the consensus estimate of $122.65 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

You May Also Be Interested In

• Wall Street's new pair trade: Long software, short chips
• Semtech Corp. (SMTC) Reiterated at Buy by StoneX Amid Strong Market Demand
• NextEra Energy plans investor meetings, reaffirms earnings outlook